Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

DRUGS OF ABUSE PANEL - ANVISA Registration 10071770931

Access comprehensive regulatory information for DRUGS OF ABUSE PANEL in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10071770931 and manufactured by ABON BIOPHARM (HANGZHOU) CO LTD. The registration is held by ABBOTT DIAGNOSTICOS RAPIDOS S.A. with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including HANGZHOU ALLTEST BIOTECH CO. LTD, HANGZHOU ALL TEST BIOTECH CO.,LTD, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
10071770931
Registration Details
ANVISA Registration Number: 10071770931
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

Multi๏ฟฝ-Drug One Step Screen Test Panel (COC150/ AMP300/ MET300/ THC/ MOP/BZO)
Risk Class II

Registration Details

10071770931

25351296065202213

50248780000161

Company Information

China
PT: CHINA, REPรšBLICA POPULAR

Dates and Status

Sep 15, 2022

VIGENTE

09/18/2025 19:00:01